2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
12
Breast Neoplasms
11
Lung Neoplasms
6
Prostatic Neoplasms
5
Colorectal Neoplasms
5
Uterine Cervical Neoplasms
4
Thyroid Neoplasms
2
Smoking Cessation
2
Motor Activity
2
Lymphoma
2
Hematologic Neoplasms
2
Communication
2
Uveal Melanoma
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Thyroid Diseases
1
Substance-Related Disorders
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Rectal Neoplasms
1
Patient Preference
1
Patient Acceptance of Health Care
1
Papillomavirus Infections
1
Papillary Thyroid Microcarcinoma
1
Neoplasms, Plasma Cell
1
Interventions
selpercatinib
3
Sorafenib
3
cabozantinib
2
Thyroid (USP)
2
Sodium
2
Radiofrequency Ablation
2
Metformin
2
Data Collection
2
vandetanib
1
tomivosertib
1
temsirolimus
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
lenvatinib
1
binimetinib
1
apatinib
1
acetaminophen, codeine drug combination
1
Watchful Waiting
1
Vitamin B 12
1
Tramadol
1
Thyroxine
1
Thyrotropin-Releasing Hormone
1
Thyroidectomy
1
Technetium Tc 99m Sestamibi
1
Surgical Procedures, Operative
1
Pemetrexed
1
Panobinostat
1
Observation
1
Negative-Pressure Wound Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Diseases
×
Focus Groups
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled